Abstract
Background/Objectives
To evaluate outcomes from all British military patients who underwent eye removal during the Iraq and Afghanistan wars.
Subjects/Methods
Retrospective case note review of all patients (n = 19) who had undergone either evisceration or enucleation, on a database of all military patients repatriated to the Royal Centre for Defence Medicine, Birmingham.
Results
Twenty eye removals were performed on 19 patients, of which 14 (70%) were eviscerations and 6 (30%) were enucleations. Orbital wall fractures were seen in 12 (61%) patients, with orbital floor fractures being the most common. The eye removal was a primary procedure in five of fourteen eviscerations, and five of six enucleations. Complications were seen after four (28.6%) eviscerations patients and two (33.3%) enucleations. Postoperative pain was problematic after three (21.4%) eviscerations but no enucleations. Orbital implants were placed during three of the five primary enucleations, with good outcomes in two. One patient however required implant retrieval and wound washout due to a high risk of infection and communication with the intra-cranial space.
Conclusions
Evisceration and enucleation are both viable options in the management of severe ocular trauma in military patients. Evisceration and enucleation have similar complication rates and outcomes, and both have low rates of sympathetic ophthalmia. Primary orbital implants can be at high risk in cases with orbital roof fracture, but can provide good outcomes in select patients.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Abbotts R, Harrison SE, Cooper GL. Primary blast injuries to the eye: a review of the evidence. J R Army Med Corps. 2007;153:119–23.
Taylor MA, Diamond T The British Military Surgery Pocket Book. P. Roberts (ed.). 112 × 188 mm. Pp. 720. Illustrated. 2004. British Army Publication. Br J Surg. 2006;93:1150. https://doi.org/10.1002/bjs.5548.
Blanch RJ, Bindra MS, Jacks AS, Scott RAH. Ophthalmic injuries in British Armed Forces in Iraq and Afghanistan. Eye. 2011;25:218–23. https://doi.org/10.1038/eye.2010.190.
Zheng C, Wu AY. Enucleation versus evisceration in ocular trauma: a retrospective review and study of current literature. Orbit. 2013;32:356–61. https://doi.org/10.3109/01676830.2013.764452.
Weichel ED, Colyer MH, Ludlow SE, Bower KS, Eiseman AS. Combat ocular trauma visual outcomes during operations iraqi and enduring freedom. Ophthalmology. 2008;115:2235–45. https://doi.org/10.1016/j.ophtha.2008.08.033.
Heier JS, Enzenauer RW, Wintermeyer SF, Delaney M, LaPiana FP. Ocular injuries and diseases at a combat support hospital in support of Operations Desert Shield and Desert Storm. Arch Ophthalmol. 1993;111:795–8.
Kuhn F, Morris R, Witherspoon CD, Mann L. Epidemiology of blinding trauma in the United States Eye Injury Registry. Ophthalmic Epidemiol. 2006;13:209–16. https://doi.org/10.1080/09286580600665886.
Colyer MH, Chun DW, Bower KS, Dick JSB, Weichel ED. Perforating globe injuries during operation Iraqi Freedom. Ophthalmology. 2008;115:2087–93. https://doi.org/10.1016/j.ophtha.2008.05.013.
Yousuf SJ, Jones LS, Kidwell EDJ. Enucleation and evisceration: 20 years of experience. Orbit. 2012;31:211–5. https://doi.org/10.3109/01676830.2011.639477.
Migliori ME. Enucleation versus evisceration. Curr Opin Ophthalmol. 2002;13:298–302.
Nakra T, Simon GJBen, Douglas RS, Schwarcz RM, McCann JD, Goldberg RA. Comparing outcomes of enucleation and evisceration. Ophthalmology. 2006;113:2270–5.
Tari AS, Malihi M, Kasaee A, et al. Enucleation with hydroxyapatite implantation versus evisceration plus scleral quadrisection and alloplastic implantation. Ophthalmic Plast Reconstr Surg. 2009;25:130–3.
Goto H, Rao NA. Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin. 1990;30:279–85.
Lubin JR, Albert DM, Weinstein M. Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913–1978). Ophthalmology. 1980;87:109–21.
D’Orazio TJ, Niederkorn JY. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology. 1998;95:47–55.
Lin H-H, Faunce DE, Stacey M, et al. The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med. 2005;201:1615–25. https://doi.org/10.1084/jem.20042307.
Sonoda K-H, Stein-Streilein J. Ocular immune privilege and CD1d-reactive natural killer T cells. Cornea. 2002;21(2 Suppl 1):S33–8.
Albert DM, Diaz-Rohena R. A historical review of sympathetic ophthalmia and its epidemiology. Surv Ophthalmol. 1989;34:1–14. https://doi.org/10.1016/0039-6257(89)90125-2.
Rao NA, Robin J, Hartmann D, Sweeney JA, Marak GEJ. The role of the penetrating wound in the development of sympathetic ophthalmia experimental observations. Arch Ophthalmol. 1983;101:102–4.
Abu El-Asrar AM, Struyf S, Van den Broeck C, et al. Expression of chemokines and gelatinase B in sympathetic ophthalmia. Eye. 2007;21:649–57. https://doi.org/10.1038/sj.eye.6702342.
Auw-Haedrich C, Loeffler KU, Witschel H. Sympathetic ophthalmia: an immunohistochemistry study of four cases. Ger J Ophthalmol. 1996;5:98–103.
Aziz HA, Flynn HW, Young RC, Davis JL, Dubovy SR. Sympathetic ophthalmia: clinicopathologic correlation in a consecutive case series. Retina. 2015;35:1696–703. https://doi.org/10.1097/IAE.0000000000000506.
Shah DN, Piacentini MA, Burnier MN, McLean IW, Nussenblatt RB, Chan CC. Inflammatory cellular kinetics in sympathetic ophthalmia a study of 29 traumatized (exciting) eyes. Ocul Immunol Inflamm. 1993;1:255–62. https://doi.org/10.3109/09273949309085026.
Chan CC, Roberge RG, Whitcup SM, Nussenblatt RB. 32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md., from 1982 to 1992. Arch Ophthalmol. 1995;113:597–600.
Alfaro DV, Liggett PE. Management of the opaque media eye with no light perception. In: Alfaro DVIIILP, editor. Vitreoretinal Surgery of the Injured Eye. Philidelphia, PA, USA: Lippincott-Raven; 1999:365.
Makley TA Jr, Azar A. Sympathetic ophthalmia: a long-term follow-up. Arch Ophthalmol. 1978;96:257–62.
du Toit N, Motala MI, Richards J, Murray ADN, Maitra S. The risk of sympathetic ophthalmia following evisceration for penetrating eye injuries at Groote Schuur Hospital. Br J Ophthalmol. 2008;92:61–63. https://doi.org/10.1136/bjo.2007.120600.
Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol. 2000;84:259–263.
Bilyk JR. Enucleation, evisceration, and sympathetic ophthalmia. Curr Opin Ophthalmol. 2000;11:372–86. https://doi.org/10.1097/00055735-200010000-00015.
Savar A, Andreoli MT, Kloek CE, Andreoli CM. Enucleation for open globe injury. Am J Ophthalmol. 2009;147:595–600.e1. https://doi.org/10.1016/j.ajo.2008.10.017.
Hui JI. Outcomes of orbital implants after evisceration and enucleation in patients with endophthalmitis. Curr Opin Ophthalmol. 2010;21:375–9. https://doi.org/10.1097/ICU.0b013e32833b7a56.
Shore JW, Dieckert JP, Levine MR. Delayed primary wound closure. Use Prev implant Extrus evisceration endophthalmitis. Arch Ophthalmol. 1988;106:1303–8.
Tabatabaee Z, Mazloumi M, Rajabi MT, et al. Comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients. Ophthalmic Plast Reconstr Surg. 2011;27:114–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Meeting presentation: British Oculoplastic Surgery Society annual meeting 2015
Rights and permissions
About this article
Cite this article
Holmes, C.J., McLaughlin, A., Farooq, T. et al. Outcomes of ocular evisceration and enucleation in the British Armed Forces from Iraq and Afghanistan. Eye 33, 1748–1755 (2019). https://doi.org/10.1038/s41433-019-0480-5
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-019-0480-5
